Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 42 countries.

Website: http://www.medpace.com

Employees: 5752

HQ: (513) 579-9911

Location: Cincinnati, Ohio, US

Revenue: $1.2 billion

Medpace Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. With a mission to accelerate the global development of safe and effective medical therapeutics, Medpace leverages local regulatory and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,700 people across 41 countries. The company has a strong presence on social media platforms such as LinkedIn, Facebook, and YouTube, and has a calculated domain of medpace.com. Medpace's size is between 1000-4999 employees, and its revenue is over $1 billion. The company operates in the Major Drugs industry and has a UK zip code of N/A. Medpace's management team includes Tracy Bimmerle, executive assistant to the CEO, CFO, and chief marketing officer, Carolyn Glashagen, managing director, Vinod Nair, owner, Kevin Brady, CFO, and other experienced executives. The company's services include clinical operations, regulatory, IVRS, reference laboratories (MRL), cardiovascular core laboratory, Imagepace, clinical pharmacology (CPU), Medpace Bioanalytical Laboratory (MBL), Medpace Medical Consulting (MMC), and Medpace Medical Device (MMD), regulatory affairs and medical writing, clinical monitoring, biometrics and data sciences, safety and pharmacovigilance, quality assurance, imaging core lab, cardiovascular core lab, central laboratories, bioanalytical laboratories, Medpace Medical Device (MMD), early phase clinical research, phase II-III clinical research, RWE-late phase clinical research, medical device and diagnostics, regulatory affairs, medical writing, clinical trial management, biostatistics and data sciences, drug safety and pharmacovigilance, imaging & ECG core labs, and B2B. Medpace's tags include clinical operations, regulatory, IVRS, reference laboratories (MRL), cardiovascular core laboratory, Imagepace, clinical pharmacology (CPU), Medpace Bioanalytical Laboratory (MBL), Medpace Medical Consulting (MMC), and Medpace Medical Device (MMD), regulatory affairs and medical writing, clinical monitoring, biometrics and data sciences, safety and pharmacovigilance, quality assurance, imaging core lab, cardiovascular core lab, central laboratories, bioanalytical laboratories, Medpace Medical Device (MMD), early phase clinical research, phase II-III clinical research, RWE-late phase clinical research, medical device and diagnostics, regulatory affairs, medical writing, clinical trial management, biostatistics and data sciences, drug safety and pharmacovigilance, imaging & ECG core labs, and B2B. Overall, Medpace Inc. is a leading CRO that provides a range of services to the biotechnology, pharmaceutical, and medical device industries, with a focus on accelerating the development of safe and effective medical therapeutics. The company has a strong global presence, a large and experienced management team, and a diverse range of services that cater to the needs of its clients.